Veracyte, Inc.
VCYT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,702,634 | $2,114,043 | $2,313,538 | $3,073,313 |
| - Cash | $315,573 | $219,499 | $186,120 | $239,087 |
| + Debt | $40,453 | $50,646 | $50,501 | $50,737 |
| Enterprise Value | $2,427,514 | $1,945,190 | $2,177,919 | $2,884,963 |
| Revenue | $131,872 | $130,164 | $114,473 | $118,632 |
| % Growth | 1.3% | 13.7% | -3.5% | – |
| Gross Profit | $89,355 | $89,769 | $79,508 | $78,754 |
| % Margin | 67.8% | 69% | 69.5% | 66.4% |
| EBITDA | $24,155 | $6,739 | $6,526 | $9,696 |
| % Margin | 18.3% | 5.2% | 5.7% | 8.2% |
| Net Income | $19,137 | -$980 | $7,047 | $5,113 |
| % Margin | 14.5% | -0.8% | 6.2% | 4.3% |
| EPS Diluted | 0.24 | -0.013 | 0.088 | 0.06 |
| % Growth | 2,020.8% | -114.2% | 46.7% | – |
| Operating Cash Flow | $44,757 | $33,605 | $5,362 | $24,524 |
| Capital Expenditures | -$2,792 | -$1,286 | -$1,819 | -$4,141 |
| Free Cash Flow | $41,965 | $32,319 | $3,543 | $20,383 |